Department of Gastroenterology, South Building, Chinese People's Liberation Army General Hospital, Beijing 100853, China.
World J Gastroenterol. 2012 May 7;18(17):2121-6. doi: 10.3748/wjg.v18.i17.2121.
To determine whether serum levels of carcinoembryonic antigen (CEA) correlate with the presence of primary colorectal cancer (CRC), and/or recurrent CRC following radical resection.
A total of 413 patients with CRC underwent radical surgery between January 1998 and December 2002 in our department and were enrolled in this study. The median follow-up period was 69 mo (range, 3-118 mo), and CRC recurrence was experienced by 90/413 (21.8%) patients. Serum levels of CEA were assayed preoperatively, and using a cutoff value of 5 ng/mL, patients were divided into two groups, those with normal serum CEA levels (e.g., ≤ 5 ng/mL) and those with elevated CEA levels (> 5 ng/mL).
The overall sensitivity of CEA for the detection of primary CRC was 37.0%. The sensitivity of CEA according to stage, was 21.4%, 38.9%, and 41.7% for stages I-III, respectively. Moreover, for stage II and stage III cases, the 5-year disease-free survival rates were reduced for patients with elevated preoperative serum CEA levels (P < 0.05). The overall sensitivity of CEA for detecting recurrent CRC was 54.4%, and sensitivity rates of 36.6%, 66.7%, and 75.0% were associated with cases of local recurrence, single metastasis, and multiple metastases, respectively. In patients with normal serum levels of CEA preoperatively, the sensitivity of CEA for detecting recurrence was reduced compared with patients having a history of elevated CEA prior to radical resection (32.6% vs 77.3%, respectively, P < 0.05).
CRC patients with normal serum CEA levels prior to resection maintained these levels during CRC recurrence, especially in cases of local recurrence vs cases of metastasis.
确定癌胚抗原(CEA)血清水平是否与原发性结直肠癌(CRC)的存在以及根治性切除术后CRC 的复发相关。
本研究共纳入 1998 年 1 月至 2002 年 12 月期间在我院接受根治性手术的 413 例 CRC 患者。中位随访时间为 69 个月(范围,3-118 个月),90/413(21.8%)例患者出现 CRC 复发。术前检测 CEA 血清水平,以 5ng/mL 为截断值,将患者分为两组,即 CEA 血清水平正常(即≤5ng/mL)和 CEA 血清水平升高(即>5ng/mL)。
CEA 对原发性 CRC 的总体检测敏感性为 37.0%。根据分期,CEA 的敏感性分别为Ⅰ-Ⅲ期的 21.4%、38.9%和 41.7%。此外,对于Ⅱ期和Ⅲ期病例,术前 CEA 血清水平升高的患者 5 年无病生存率降低(P<0.05)。CEA 对检测复发性 CRC 的总体敏感性为 54.4%,局部复发、单发转移和多发转移的敏感性分别为 36.6%、66.7%和 75.0%。术前 CEA 血清水平正常的患者,其 CEA 对复发的检测敏感性低于根治性切除术前 CEA 水平升高的患者(分别为 32.6%和 77.3%,P<0.05)。
CRC 患者根治性切除术前 CEA 血清水平正常者,在 CRC 复发时仍保持此水平,尤其是在局部复发与转移病例中。